30
Participants
Start Date
March 30, 2018
Primary Completion Date
June 1, 2018
Study Completion Date
June 1, 2018
rhNGF 20μg/mL
"Study Eye (For subjects randomized to rhNGF group) Day 1: One drop instilled into study eye (35 μL, corresponding to 0.70 μg of rhNGF).~Day 2, 3, 4, 5, 6: One drop six times a day (every 2h) into study eye (210 μL, corresponding to 4.20 μg of rhNGF).~Total dose in the study eye will be 31 drops (1085 μL, equivalent to 21.7 μg rhNGF) over 6 days."
Placebo
Vehicle: formulation containing L-methionine as excipient.
WCCT Global, Cypress
Collaborators (1)
Cromsource
INDUSTRY
Dompé Farmaceutici S.p.A
INDUSTRY